Trial NCT04870112

View at ClinicalTrials.gov 
Org. Study IDs: D9072C00001
Secondary IDs: 2020-006041-18

Last trial update was posted on 2024-03-08

MeSH Interventions

Carboplatin Durvalumab Etoposide

MeSH Conditions

Carcinoma, Non-Small-Cell Lung Lung Neoplasms Small Cell Lung Carcinoma

Other Conditions

Non-Small Cell Lung Cancer Small Cell Lung Cancer

Stopping Reasons

AstraZeneca has decided to stop further enrollment and the study was terminated when all patients in Part 1 completed their last study visit. No safety issues or clinical concerns however, have been identified for this study. Part 2 was not initiated

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID